BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurosawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori infection: GASTRIC HISTOLOGY AFTER CURE OF H. PYLORI INFECTION. Alimentary Pharmacology & Therapeutics 2002;16:1923-32. [DOI: 10.1046/j.1365-2036.2002.01346.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Leung WK, Sung JJ. Pathogenesis of Pre-Neoplastic Lesions of the Stomach: Targets for Prevention. Dig Dis 2005;22:306-12. [DOI: 10.1159/000083591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
2 Malfertheiner P. Gastric Atrophy Reversible or Irreversible after <i>Helicobacter pylori</i> Eradication – An Open Question. Digestion 2011;83:250-2. [DOI: 10.1159/000321529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study. J Gastroenterol Hepatol. 2005;20:1661-1666. [PMID: 16246182 DOI: 10.1111/j.1440-1746.2005.04051.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
4 Bespalov V, Sherbakov A, Novik V, Kalinovsky V, Shamsi K, Soultanov V. Conifer Green Needle Complex in Patients with Precancerous Gastric Lesions: An Observational Pilot Study. Evid Based Complement Alternat Med 2016;2016:3848409. [PMID: 28003849 DOI: 10.1155/2016/3848409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Nardone G, Rocco A, Malfertheiner P. Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther. 2004;20:261-270. [PMID: 15274662 DOI: 10.1111/j.1365-2036.2004.02075.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 5.1] [Reference Citation Analysis]
6 Cho JH, Jeon SR, Jin SY, Park S. Analysis of factors associated with recovery of the serum pepsinogen ratio after Helicobacter pylori eradication: a long-term follow-up study in Korea. Scand J Gastroenterol 2019;54:1306-14. [PMID: 31702966 DOI: 10.1080/00365521.2019.1686058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Delchier J. Manifestations digestives de l’infection à Helicobacter pylori chez l’adulte : de la gastrite au cancer gastrique. La Presse Médicale 2008;37:519-24. [DOI: 10.1016/j.lpm.2007.07.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Kim N, Park RY, Cho SI, Lim SH, Lee KH, Lee W, Kang HM, Lee HS, Jung HC, Song IS. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up. J Clin Gastroenterol. 2008;42:448-454. [PMID: 18344895 DOI: 10.1097/mcg.0b013e318046eac3] [Cited by in Crossref: 82] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
9 Kim HJ, Choi BY, Byun TJ, Eun CS, Song KS, Kim YS, Han DS. The Prevalence of Atrophic Gastritis and Intestinal Metaplasia according to Gender, Age and Helicobacter Pylori Infection in a Rural Population. J Prev Med Public Health 2008;41:373. [DOI: 10.3961/jpmph.2008.41.6.373] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
10 Zhao J, Xu S, Gao Y, Lei Y, Zou B, Zhou M, Chang D, Dong L, Qin B. Accuracy of Endoscopic Diagnosis of Helicobacter pylori Based on the Kyoto Classification of Gastritis: A Multicenter Study. Front Oncol 2020;10:599218. [PMID: 33344250 DOI: 10.3389/fonc.2020.599218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Leodolter A, Naumann M, Malfertheiner P. Prevention of Gastric Cancer by <i>Helicobacter pylori </i>Eradication. Dig Dis 2005;22:313-9. [DOI: 10.1159/000083592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Rugge M. Gastric Cancer Risk in Patients with Helicobacter pylori Infection and Following Its Eradication. Gastroenterology Clinics of North America 2015;44:609-24. [DOI: 10.1016/j.gtc.2015.05.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
13 Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015;50:657-667. [PMID: 25901896 DOI: 10.3109/00365521.2015.1019918] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 10.3] [Reference Citation Analysis]
14 Kwon Y, Jeon S, Nam S, Shin I. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Aliment Pharmacol Ther. 2017;46:758-767. [PMID: 28799258 DOI: 10.1111/apt.14263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
15 Kang SJ, Park B, Shin CM. Helicobacter pylori Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and H. pylori Prevalence. J Clin Med. 2019;8. [PMID: 31466299 DOI: 10.3390/jcm8091324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(4): 976-978 [DOI: 10.11569/wcjd.v12.i4.976] [Reference Citation Analysis]
17 Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after Helicobacter pylori eradication: A systematic review and meta-analysis. World J Gastroenterol 2014; 20(19): 5903-5911 [PMID: 24914352 DOI: 10.3748/wjg.v20.i19.5903] [Cited by in CrossRef: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
18 Iijima K, Koike T, Abe Y, Ara N, Uno K, Imatani A, Ohara S, Shimosegawa T. Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication. J Gastroenterol 2009;44:819-25. [DOI: 10.1007/s00535-009-0066-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
19 Lv B. Is the eradication of Helicobacter pylori a way to prevent gastric cancer? Shijie Huaren Xiaohua Zazhi 2007; 15(25): 2669-2671 [DOI: 10.11569/wcjd.v15.i25.2669] [Reference Citation Analysis]
20 Virili C, Antonelli A, Santaguida MG, Benvenga S, Centanni M. Gastrointestinal Malabsorption of Thyroxine. Endocr Rev 2019;40:118-36. [PMID: 30476027 DOI: 10.1210/er.2018-00168] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 16.3] [Reference Citation Analysis]
21 Wang C, Yuan Y, Hunt RH. The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis. Am J Gastroenterol 2007;102:1789-98. [PMID: 17521398 DOI: 10.1111/j.1572-0241.2007.01335.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 6.5] [Reference Citation Analysis]
22 Leung WK, Sung JJ. Chemoprevention of gastric cancer: . European Journal of Gastroenterology & Hepatology 2006;18:867-71. [DOI: 10.1097/00042737-200608000-00010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
23 Raghunath AS, O'Morain C, McLoughlin RC. Review article: the long-term use of proton-pump inhibitors. Aliment Pharmacol Ther. 2005;22 Suppl 1:55-63. [PMID: 16042660 DOI: 10.1111/j.1365-2036.2005.02611.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 95] [Article Influence: 6.1] [Reference Citation Analysis]
24 Tari A, Kitadai Y, Sumii M, Sasaki A, Tani H, Tanaka S, Chayama K. Basis of Decreased Risk of Gastric Cancer in Severe Atrophic Gastritis with Eradication of Helicobacter pylori. Dig Dis Sci 2007;52:232-9. [DOI: 10.1007/s10620-006-9411-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
25 Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, Chen Y, Wang JB, Du YQ, Lu NH; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori and Peptic Ulcer. Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter. 2018;23:e12475. [PMID: 29512258 DOI: 10.1111/hel.12475] [Cited by in Crossref: 102] [Cited by in F6Publishing: 94] [Article Influence: 25.5] [Reference Citation Analysis]
26 Okano A, Takakuwa H, Matsubayashi Y. DEVELOPMENT OF SPORADIC GASTRIC FUNDIC GLAND POLYP AFTER ERADICATION OF HELICOBACTER PYLORI: GASTRIC FGP AFTER ERADICATION OF HP. Digestive Endoscopy 2008;20:41-3. [DOI: 10.1111/j.1443-1661.2007.00762.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
27 Emanuele Liardo RL, Borzì AM, Spatola C, Martino B, Privitera G, Basile F, Biondi A, Vacante M. Effects of infections on the pathogenesis of cancer. Indian J Med Res 2021;153:431-45. [PMID: 34380789 DOI: 10.4103/ijmr.IJMR_339_19] [Reference Citation Analysis]
28 Venerito M, Kuester D, Wex T, Roessner A, Malfertheiner P, Treiber G. The long-term effect of Helicobacter pylori eradication on COX-1/2, 5-LOX and leukotriene receptors in patients with a risk gastritis phenotype – A link to gastric carcinogenesis. Cancer Letters 2008;270:218-28. [DOI: 10.1016/j.canlet.2008.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
29 Matysiak-Budnik T, Mégraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer. 2006;42:708-716. [PMID: 16556496 DOI: 10.1016/j.ejca.2006.01.020] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 4.8] [Reference Citation Analysis]
30 Okubo M, Tahara T, Shibata T, Nakamura M, Yoshioka D, Maeda Y, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Changes in gastric mucosal patterns seen by magnifying NBI during H. pylori eradication. J Gastroenterol. 2011;46:175-182. [PMID: 20967557 DOI: 10.1007/s00535-010-0335-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
31 Hojo M, Ueda K, Takeda T, Akazawa Y, Ueyama H, Shimada Y, Asaoka D, Nagahara A. The relationship between Helicobacter pylori infection and reflux esophagitis and the long-term effects of eradication of Helicobacter pylori on reflux esophagitis. Therap Adv Gastroenterol 2021;14:17562848211059942. [PMID: 34917172 DOI: 10.1177/17562848211059942] [Reference Citation Analysis]
32 Miwa H, Nakajima K, Yamaguchi K, Fujimoto K, Veldhuyzen VAN Zanten SJ, Kinoshita Y, Adachi K, Kusunoki H, Haruma K. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26:257-264. [PMID: 17593071 DOI: 10.1111/j.1365-2036.2007.03367.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
33 Romano M, Ricci V, Zarrilli R. Mechanisms of Disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemoprevention. Nat Rev Gastroenterol Hepatol 2006;3:622-32. [DOI: 10.1038/ncpgasthep0634] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
34 Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005;54:1536-40. [PMID: 15985559 DOI: 10.1136/gut.2005.072009] [Cited by in Crossref: 227] [Cited by in F6Publishing: 221] [Article Influence: 13.4] [Reference Citation Analysis]
35 Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther. 2004;19:1181-1188. [PMID: 15153171 DOI: 10.1111/j.1365-2036.2004.01948.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
36 Okubo M, Tahara T, Shibata T, Nakamura M, Kamiya Y, Yoshioka D, Maeda Y, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Usefulness of magnifying narrow-band imaging endoscopy in the Helicobacter pylori-related chronic gastritis. Digestion. 2011;83:161-166. [PMID: 21266810 DOI: 10.1159/000321799] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
37 Kawai T, Kawakami K, Kudo T, Takei K, Moriyasu F, Takagi Y, Aoki T, Koyanagi Y, Serizawa H, Rinbara E, Noguchi M, Sasatsu M. Correlation between serum pepsinogen levels and gastric mucosal histological findings before and after Helicobacter pylori eradication therapy. Dig Endosc 2004;16:122-8. [DOI: 10.1111/j.1443-1661.2003.00324.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
38 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
39 Zhou JJ, Shi X, Zheng SP, Tang D, Cai T, Yao Y, Wang F. Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China. Helicobacter 2020;25:e12755. [PMID: 32914914 DOI: 10.1111/hel.12755] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Leodolter A, Ebert MP, Peitz U, Wolle K, Kahl S, Vieth M, Malfertheiner P. Prevalence of H pylori associated ‘high risk gastritis’ for development of gastric cancer in patients with normal endoscopic findings. World J Gastroenterol 2006; 12(34): 5509-5512 [PMID: 17006989 DOI: 10.3748/wjg.v12.i34.5509] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
41 Fang J, Du YQ, Liu WZ, Ren JL, Li YQ, Chen XY, Lv NH, Chen YX, Lv B; Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on chronic gastritis (2017, Shanghai): 2017 Chinese consensus on CG. Journal of Digestive Diseases 2018;19:182-203. [DOI: 10.1111/1751-2980.12593] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
42 Kwon YH, Heo J, Lee HS, Cho CM, Jeon SW. Failure of Helicobacter pylori eradication and age are independent risk factors for recurrent neoplasia after endoscopic resection of early gastric cancer in 283 patients. Aliment Pharmacol Ther. 2014;39:609-618. [PMID: 24461252 DOI: 10.1111/apt.12633] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
43 Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, Dítê P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Herszényi L, Nagy P; HELIX Study Investigators. Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers. Scand J Gastroenterol 2010;45:1048-58. [PMID: 20509752 DOI: 10.3109/00365520903575737] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
44 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1744-1746 [DOI: 10.11569/wcjd.v12.i7.1744] [Reference Citation Analysis]
45 Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G. The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter. 2007;12 Suppl 2:32-38. [PMID: 17991174 DOI: 10.1111/j.1523-5378.2007.00563.x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 119] [Article Influence: 9.0] [Reference Citation Analysis]
46 Salles N. Is stomach spontaneously ageing? Pathophysiology of the ageing stomach. Best Pract Res Clin Gastroenterol 2009;23:805-19. [PMID: 19942159 DOI: 10.1016/j.bpg.2009.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
47 Nardone G, Rocco A. Chemoprevention of Gastric Cancer: Role of COX-2 Inhibitors and Other Agents. Dig Dis 2005;22:320-6. [DOI: 10.1159/000083593] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
48 Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol. 2005;40:302-311. [PMID: 15932171 DOI: 10.1080/00365520410010625] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 1.9] [Reference Citation Analysis]
49 Rugge M, Russo VM, Guido M. Review article: what have we learnt from gastric biopsy? Aliment Pharmacol Ther 2003;17 Suppl 2:68-74. [PMID: 12786616 DOI: 10.1046/j.1365-2036.17.s2.15.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
50 Kawai T, Kawakami K, Kataoka M, Takei K, Taira S, Itoi T, Moriyasu F, Takagi Y, Aoki T, Serizawa H, Rimbara E, Noguchi N, Sasatsu M. Correlation of serum pepsinogen with histological atrophy following successful Helicobacter pylori eradication. Aliment Pharmacol Ther Symp Series 2006;2:23-30. [DOI: 10.1111/j.1746-6342.2006.00022.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kawai T, Kawakami K, Kataoka M, Takei K, Taira S, Itoi T, Moriyasu F, Takagi Y, Aoki T, Serizawa H, Rimbara E, Noguchi N, Sasatsu M. Correlation of serum pepsinogen with histological atrophy following successful Helicobacter pylori eradication: PEPSINOGEN AND HISTOLOGICAL FINDINGS AFTER H. PYLORI ERADICATION. Alimentary Pharmacology & Therapeutics 2006;24:23-30. [DOI: 10.1111/j.1365-2036.2006.00022.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
52 Salih BA, Abasiyanik MF, Saribasak H, Huten O, Sander E. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology. Dig Dis Sci. 2005;50:1517-1522. [PMID: 16110845 DOI: 10.1007/s10620-005-2871-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
53 Fang JY, Liu WZ, Shi Y, Ge ZZ, Xiao SD. Consensus on chronic gastritis in China--Second National Consensus Meeting on Chronic Gastritis (14-16 September 2006 Shanghai, China). J Dig Dis. 2007;8:107-119. [PMID: 17532824 DOI: 10.1111/j.1443-9573.2007.00295.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
54 Delchier JC. [How to prevent precancerous gastric lesions]. Gastroenterol Clin Biol 2004;28:D172-7. [PMID: 15213677 DOI: 10.1016/s0399-8320(04)95001-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Hunt RH. Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? Am J Med 2004;117 Suppl 5A:86S-91S. [PMID: 15478858 DOI: 10.1016/j.amjmed.2004.07.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
56 Chung CS, Woo HS, Chung JW, Jeong SH, Kwon KA, Kim YJ, Kim KO, Park DK. Risk Factors for Metachronous Recurrence after Endoscopic Submucosal Dissection of Early Gastric Cancer. J Korean Med Sci. 2017;32:421-426. [PMID: 28145644 DOI: 10.3346/jkms.2017.32.3.421] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
57 Hojo M, Asaoka D, Takeda T, Shimada Y, Matsumoto K, Matsumoto K, Yatagai N, Akazawa Y, Ueda K, Ueyama H, Nagahara A. Randomized controlled study on the effects of triple therapy including vonoprazan or rabeprazole for the second-line treatment of Helicobacter pylori infection. Therap Adv Gastroenterol 2020;13:1756284820966247. [PMID: 33240391 DOI: 10.1177/1756284820966247] [Reference Citation Analysis]
58 Nardone G, Rocco A, Compare D, De Colibus P, Autiero G, Pica L, de Nucci G, Gasbarrini G. Is screening for and surveillance of atrophic gastritis advisable? Dig Dis. 2007;25:214-217. [PMID: 17827942 DOI: 10.1159/000103887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
59 Du Y, Zhu H, Liu J, Li J, Chang X, Zhou L, Chen M, Lu N, Li Z. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). J Gastroenterol Hepatol. 2020;35:624-629. [PMID: 31788864 DOI: 10.1111/jgh.14947] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]